OBBI is supported by CeBBOc (Défi clé Biothérapies en Occitanie), a regional initiative aimed at structuring and accelerating the biotherapies sector in Occitanie. CeBBOc contributes to OBBI’s development by co-funding the platform’s Business Development position, helping to foster partnerships and promote the transfer of organoid and extracellular vesicle technologies to industry and clinical applications.

This work has received financial support from the CeBBOc Key Challenge, funded by the Occitanie Region, France. However, the content of this publication is solely the responsibility of its authors.